|
1) Kuro-o M, Matsumura Y, Aizawa H, et al. Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature. 1997; 390: 45-51
|
|
|
|
2) Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis. 1998; 32 Suppl: S112-9
|
|
|
|
|
3) Aizawa H, Saito Y, Nakamura T, et al. Downregulation of the Klotho gene in the kidney under sustained circulatory stress in rats. Biochem Biophys Res Commun. 1998; 249: 865-71
|
|
|
|
|
|
4) Koh N, Fujimori T, Nishiguchi S, et ai. Severely reduced production of Klotho in human chronic renal failure kidney. Biochem Biophys Res Commun. 2001; 280: 1015-20
|
|
|
|
|
|
5) Kurosu H, Yamamoto M, Clark JD, et al. Suppression of aging in mice by the hormone Klotho. Science. 2005; 309: 1829-33
|
|
|
|
|
|
6) Torres PU, Prié D, Molina-Blétry V, et al. An antiaging protein involved in mineral and vitamin D metabolism. Kidney Int. 2007; 71: 730-7
|
|
|
|
|
|
7) Haruna Y, Kashihara N, Satoh M, et al. Amelioration of progressive renal injury by genetic manipulation of Klotho gene. Proc Natl Acad Sci U S A. 2007; 104: 2331-6
|
|
|
|
|
|
8) Cha SK, Ortega B, Kurosu H, et al. Removal of sialic acid involving Klotho causes cell-surface retention of TRPV5 channel via binding to galectin-1. Proc Natl Acad Sci U S A. 2008; 105: 9805-10
|
|
|
|
|
|
9) Cha SK, Hu MC, Kurosu H, et al. Regulation of renal outer medullary potassium channel and renal K(＋) excretion by Klotho. Mol Pharmacol. 2009; 76: 38-46
|
|
|
|
|
|
10) Liu H, Fergusson MM, Castilho RM, et al. Augmented Wnt signaling in a mammalian model of accelerated aging. Science. 2007; 317: 803-6
|
|
|
|
|
|
11) Doi S, Zou Y, Togao O, et al. Klotho inhibits transforming growth factor-β1 (TGF-β1) signaling and suppresses renal fibrosis and cancer metastasis in mice. J Biol Chem. 2011; 286: 8655-65
|
|
|
|
|
|
12) Bose S, French S, Evans FJ, et al. Metabolic network control of oxidative phosphorylation: multiple roles of inorganic phosphate. J Biol Chem. 2003; 278: 39155-65
|
|
|
|
|
|
13) Stubbs JR, Liu S, Tang W, et al. Role of hyperphosphatemia and1, 25-dihydroxyvitamin D in vascular calcification and mortality infibroblastic growth factor 23 null mice. J Am Soc Nephrol. 2007; 18: 2116–24
|
|
|
|
|
|
14) Ohnishi M, Razzaque MS. Dietary and genetic evidence for phosphate toxicity accelerating mammalian aging. FASEB J. 2010; 24: 3562-71
|
|
|
|
|
|
15) Tonelli M, Sacks F, Pfeffer M, et al. Relation between serum phosphate level and cardiovascular event rate in people with coronary disease. Circulation. 2005; 112: 2627–33
|
|
|
|
|
|
16) Ganesh SK, Stack AG, Levin NW, et al. Association of elevated serum PO(4), Ca × PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients. J Am Soc Nephrol. 2001; 12: 2131–8
|
|
|
|
|
|
17) Matsumura Y, Aizawa H, Shiraki-Iida T, et al. Identification of the human klotho gene and its two transcripts encoding membrane and secreted klotho protein. Biochem Biophys Res Commun. 1998; 242: 626-30
|
|
|
|
|
|
18) Ohyama Y, Kurabayashi M, Masuda H, et al. Molecular cloning of rat klotho cDNA: markedly decreased expression of klotho by acute inflammatory stress. Biochem Biophys Res Commun. 1998; 251: 920-5
|
|
|
|
|
|
19) Imura A, Iwano A, Tohyama O, et al. Secreted Klotho protein in sera and CSF: implication for post-translational cleavage in release of Klotho protein from cell membrane. FEBS Lett. 2004; 565: 143-7
|
|
|
|
|
|
20) 古川雄祐. Epigeneticsと血液疾患. 臨床血液. 2008; 49: 1472-82
|
|
|
|
|
21) 古川雄祐, 和田妙子. クロマチンおよびDNAの修飾を標的とする分子標的治療薬. 成人病と生活習慣病. 2008; 38: 642-6
|
|
|
|
|
|
22) Kawano K, Ogata N, Chiano M, et al. Klotho gene polymorphisms associated with bone density of aged postmenopausal women. J Bone Mineral Res. 2002; 17: 1744-51
|
|
|
|
|
|
23) Shimokata H, Ando F, Furukawa Y, et al. Klotho gene promoter polymorphism and cognitive impairment. Geriatr Gerontol Int. 2006; 6: 136-41
|
|
|
|
|
|
24) Simoyama Y, Nishio K, Hamajima N, et al. KLOTHO gene polymorphisms G-395A and C1818T are associated with lipid and glucose metabolism, bone mineral density and systolic blood pressure in Japanese healthy subjects. Clin Chim Acta. 2009; 406: 134-8
|
|
|
|
|
|
25) Narumiya H, Sasaki S, Kuwahara N, et al. HMG-CoA reductase inhibitors up-regulate anti-aging klotho mRNA via RhoA inactivation in IMCD3 cells. Cardiovasc Res. 2004; 64: 331-6
|
|
|
|
|
|
26) Morishita K, Shirai A, Kubota M, et al. The progression of aging in klotho mutant mice can be modified by dietary phosphorus and zinc. J Nutr. 2001; 131: 3182-8
|
|
|
|
|
|
27) Tsujikawa H, Kurotaki Y, Fujimori T, et al. Klotho, a gene related to a syndrome resembling human premature aging, functions in a negative regulatory circuit of vitamin D endocrine system. Mol Endocrinol. 2003; 17: 2393-403
|
|
|
|
|
|
28) Mizuno I, Takahashi Y, Okimura Y, et al. Upregulation of the klotho gene expression by thyroid hormone and during adipose differentiation in 3T3-L1 adipocytes. Life Sci. 2001; 68: 2917-23
|
|
|
|
|
|
29) Chihara Y, Rakugi H, Ishikawa K, et al. Klotho protein promotes adipocyte differentiation. Endocrinology. 2006; 147: 3835-42
|
|
|
|
|
|
30) Zhang H, Li Y, Fan Y, et al. Klotho is a targe gene of PPRR-γ. Kidney Int. 2008; 74: 732-9
|
|
|
|
|
|
31) Kurosu H, Ogawa Y, Miyoshi M, et al. Regulation of fibroblast growth factor-23 signaling by klotho. J Biol Chem. 2006; 281: 6120-3
|
|
|
|
|
|
32) Kusano E. Mechanism by which chronic kidney disease causes cardiovascular disease and the measures to manage this phenomenon. Clin Exp Nephrol. 2011 Jun 1. [Epub ahead of print]
|
|
|
|
|